Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement

Gynecol Oncol. 2024 Mar:182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.

Authors

Gretchen E Glaser¹, Sean C Dowdy²

Affiliations

¹ Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.
² Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA; Robert D. and Patricia E. Kern Center for the Science of Healthcare Deliver, Mayo Clinic, Rochester, MN, USA. Electronic address: dowdy.sean@mayo.edu.

PMID: 38521580
DOI: 10.1016/j.ygyno.2024.03.012

No abstract available

Publication types

Editorial

MeSH terms

Endometrial Neoplasms* / pathology
Endometrial Neoplasms* / surgery
Female
Humans
Lymph Node Excision
Lymph Nodes / pathology
Neoplasm Staging
Sentinel Lymph Node Biopsy
Sentinel Lymph Node* / pathology